Evidence for multiple sclerosis as an infectious disease

Acta Neurologica Scandinavica

Volumn 91, Issue 161 S, 1995, Pages 34-42

  Cook, S D ^a,b   Rohowsky Kochan C ^a,b   Bansil, S ^a,b   Dowling, P C ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

infection; multiple sclerosis; virus

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DEMYELINATION; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; VIRUS INFECTION; ANIMAL; ARTICLE; CANINE DISTEMPER MORBILLIVIRUS; DEMYELINATING DISEASE; DOG; DOG DISEASE; VIROLOGY;

ANIMAL; DEMYELINATING DISEASES; DISTEMPER; DISTEMPER VIRUS, CANINE; DOG DISEASES; DOGS; HUMAN; MULTIPLE SCLEROSIS;

EID: 0029189407     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1995.tb05854.x     Document Type: Article

References (104)

1. Multiple sclerosis and viruses: an overview.
2. The virology of demyelinating diseases.
3. Virus‐induced demyelination in man: models for multiple sclerosis.
4. Pathogenesis of multiple sclerosis ‐the immune diathesis and the role of viruses.
5. Evidence for a viral etiology of multiple sclerosis
6. Viruses and the pathogenesis of multiple sclerosis.
7. Epidemiologic contributions to multiple sclerosis: an overview.
8. A population‐based study of multiple sclerosis in twins: Update.
9. Multiple sclerosis in twins.
10. Multiple sclerosis and childhood infections.
11. The multiple causes of multiple sclerosis: the importance of infections in childhood.
12. A study of measles virus and canine distemper virus antibodies and of childhood infections in multiple sclerosis patients and controls.
13. Multiple sclerosis and age of exposure to childhood diseases and animals: Cases and their friends.
14. Multiple sclerosis in the Orkney and Shetland Islands. II. The search for an exogenous aetiology.
15. Infections in childhood and adolescence in multiple sclerosis.
16. Guillain‐Barre syndrome: its epidemiology and association with influenza vaccination.
17. Multiple sclerosis and childhood infections.
18. A case‐control study of multiple sclerosis.
19. Multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological features.
20. Multiple sclerosis in Iceland. 1. Evidence of a post‐war epidemic.
21. The incidence of multiple sclerosis in Newfoundland and Labrador, 1960–1984.
22. Distemper and multiple sclerosis in Sitka, Alaska.
23. Declining incidence of multiple sclerosis in the Orkney Islands.
24. Unusual occurrence on a tropical island of multiple sclerosis
25. Central nervous system manifestations of Lyme disease.
26. The aetiological agent of cat scratch disease.
27. Experimental models of virus‐induced demyelination of the central nervous system.
28. Detection of JC virus DNA by polymerase chain reaction in patients with progressive multifocal leukoencephalopathy.
29. Morphological spectrum, distribution and clinical correlation of white matter lesions in AIDS brains.
30. Jamaican (tropical) myeloneuropathy
31. Epitopes of streptococcal M proteins shared with cardiac myosin.
32. Role of infection in Gullain‐Barré syndrome. Laboratory confirmation of herpesviruses in 41 cases.
33. Dog ownership among multiple sclerosis patients and their level of measles antibodies. A case control study.
34. Mycoplasma antibody in Guillain‐Barré syndrome and other neurological disorders.
35. Guillain‐Barré syndrome and Campylobacter jejuni: a serological study.
36. Cold agglutinin‐positive Guillain‐Barré syndrome.
37. Penner's serotype 4 of Campylobacter jejuni has a Iipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GDI a epitope.
38. Effects of canine distemper virus on lymphoid function in vitro and in vivo.
39. Measles antibodies in multiple scelerosis.
40. Potential role of paramyxoviruses in multiple sclerosis.
41. Viral antibodies in multiple sclerosis.
42. Impaired measles virus‐specific cytotoxic T cell responses in multiple sclerosis.
43. Measles virus neucleotide sequences: detection by hybridization in situ.
44. Examination of eight cases of multiple sclerosis and 56 neurological and non‐neurological controls for genomic sequences of measles virus, canine distemper virus, simian virus 5 and rubella virus.
45. No measles virus genetic information detected in multiple sclerosis‐derived brains.
46. Measles virus nucleic acid sequences in human brain.
47. Measles vaccination does not prevent multiple sclerosis.
48. Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients.
49. Human coronavirus gene expression in the brains of multiple sclerosis patients.
50. Epstein‐Barr nuclear antigen antibody titers in multiple sclerosis.
51. Demyelinating disease after neurologically complicated primary Epstein‐Barr virus infection.
52. Multiple sclerosis and Epstein‐Barr virus.
53. Epstein‐Barr virus infection and antibody synthesis in patients with multiple sclerosis.
54. Detection of orona virus RNA and antigen in MS brain.
55. Histopathologic and immunocytochemical studies of distemper in seals.
56. Viral distemper now found in porpoises.
57. Animal model of human disease. Animal model: distemper associated demyelinating encephalomyelitis.
58. Canine distemper in black‐footed ferrets from Wyoming.
59. Chronic encephalmyelitis caused by canine distemper virus in a Bengal tiger.
60. Susceptibility of young lions to dog distemper.
61. Neurological disorders in the racoon in the northeastern United States.
62. Demyelination in experimental canine distemper virus infection: immunological, pathological and immunohistological studies.
63. Natural infection with canine distemper virus in a Japanese monkey.
64. Chronic relapsing demyelinating encephalomyelitis associated with persistent canine distemper virus infection.
65. Production of immuno‐globulin G and increased antiviral antibody in cerebrospinal fluid of dogs with delayed onset canine distemper viral encephalitis.
66. Pilot survey of household pets among veterans with multiple sclerosis and age‐matched controls.
67. Multiple sclerosis unrelated to dog exposure.
68. Epidemiologic studies on multiple sclerosis.
69. Man, dogs, and hydatid disease.
70. Multiple sclerosis and canine distemper.
71. Multiple sclerosis and distemper in Iceland: 1966–1978.
72. Multiple sclerosis in the Faroe Islands. 4. The lack of a relationship between canine distemper and the epidemics of MS.
73. Multiple sclerosis in Iceland: 1900–1985.
74. Multiple sclerosis and canine distemper on Key West, Florida.
75. Environmental studies in multiple sclerosis.
76. Multiple sclerosis and dogs.
77. A possible association between house pets and multiple sclerosis.
78. Further evidence of a possible association between house dogs and multiple sclerosis.
79. Viral infections in patients with multiple sclerosis and HLA‐DR matched controls.
80. Epidemiologic study of multiple sclerosis in Israel, Part I. An overall review of methods and findings.
81. Multiple sclerosis and exposure to house pets.
82. Multiple sclerosis, solvents and pets: a case‐referent study.
83. Multiple sclerosis and exposure to solvents, ionizing radiation, and animals.
84. Reappraisal of possible aetological factors in multiple sclerosis.
85. How multiple sclerosis is related to animal illness, stress, and diabetes.
86. Multiple sclerosis and dog ownership: a case‐control investigation.
87. Multiple sclerosis and house pets.
88. Pet ownership, distemper antibodies and multiple sclerosis.
89. A radioimmunoassay search for measles and distemper antigens in subacute sclerosing panencephalitis and multiple sclerosis brain tissues.
90. Failure to detect measles virus proteins in brain tissue of patients with multiple sclerosis.
91. Neutralizing antibodies to canine distemper and measles virus in multiple sclerosis.
92. Search for canine‐distemper antibodies in multiple sclerosis: a detailed virological evaluation.
93. Viruses and multiple sclerosis.
94. Measles and canine distemper antibody: presence in sera from patients with multiple sclerosis and matched control subjects.
95. The nucleotide sequence of the gene encoding the attachment protein H of canine distemper virus.
96. Prediction of protein antigenic determinants from amino acid sequences.
97. New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
98. An analysis of the 'epidemic' of MS in the Faroe Islands. II. Biostatistical aspects.